Skip to Content

Semaglutide (Ozempic)

Once-weekly GLP-1 injection for weight management. Consult your doctor for dosage.

4 doses (1 month supply)


₹ 8,096.00 ₹ 8,800.00

  • Dosage

Ozempic® is a prescription medication used to help adults with type 2 diabetes manage blood sugar levels. It belongs to a class of medicines called GLP-1 receptor agonists, which mimic a natural hormone that regulates blood sugar, appetite, and digestion.

In addition to improving glucose control, Ozempic may help reduce the risk of major cardiovascular events such as heart attack or stroke in adults with diabetes and established heart disease.


How Ozempic Works

Ozempic works by activating GLP-1 receptors, helping regulate several important metabolic functions.

It helps the body:

• Release insulin when blood sugar levels rise

• Reduce glucose production by the liver

• Slow digestion to increase feelings of fullness

• Decrease appetite and food cravings

These effects help improve blood sugar stability and overall metabolic health.


How It’s Taken

Ozempic is administered as a once-weekly injection under the skin.

Common injection sites include:

• Abdomen

• Thigh

• Upper arm

For best results, injections should be taken on the same day each week and combined with healthy lifestyle habits such as balanced nutrition and regular physical activity.


Potential Benefits

Treatment with Ozempic may help:

• Improve blood sugar control

• Support appetite regulation

• Reduce cardiovascular risk in eligible patients

• Improve overall metabolic health


Common Side Effects

Some individuals may experience side effects, particularly during the first few weeks of treatment.

Common effects include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Dizziness

These symptoms are usually temporary and improve as the body adjusts.


Safety Information

Before starting Ozempic, speak with your doctor if you have a history of:

• Pancreatitis

• Thyroid cancer

• Severe gastrointestinal disorders

Ozempic should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Your healthcare provider should also be informed about any medications, supplements, or existing health conditions before starting treatment.


Missed Dose

If you miss a scheduled dose:

• Take it as soon as possible within 5 days

• If more than 5 days have passed, skip the missed dose and continue with your regular schedule

Do not take two doses at the same time.


Key Facts

Drug Class: GLP-1 Receptor Agonist

Administration: Once-weekly injection

Used For: Type 2 diabetes management and cardiovascular risk reduction

Habit Forming: No

Wegovy® is a prescription medication containing semaglutide, a GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight with related health conditions. It works by mimicking a natural hormone that regulates appetite, food intake, and digestion.

Wegovy is typically prescribed alongside reduced-calorie nutrition and increased physical activity to support long-term weight management and metabolic health.

Common Questions

Answered
directly.

GLP-1 medication is not prescribed universally. Every patient undergoes a thorough clinical evaluation — reviewing medical history, current conditions, and relevant investigations — before any prescription is made. The decision is always made by the doctor, not an algorithm.

Clinical data shows patients on GLP-1 therapy lose around 12–15% of body weight during treatment when combined with dietary guidance. Results vary depending on physiology, adherence, and dosage.

If suitable, your doctor creates a personalised dosing protocol. You receive a prescription, monitoring schedule, and direct access to your care team. Early treatment usually includes weekly check-ins.

GLP-1 medication works with the body's appetite signals, meaning rigid dieting often becomes unnecessary. Your doctor will provide practical nutritional guidance that complements the medication.

The most common side effects are nausea, mild fatigue, and appetite changes in the early weeks. These are managed by starting with a low dose and adjusting gradually under medical supervision.

Treatment duration varies. Some patients continue for 12–18 months, while others transition to maintenance earlier. The timeline depends on your medical progress.